6 August 2025 in Journal of the American Heart Association
Background: Bacterial DNA from the oral cavity, respiratory tract, gut, and skin has been detected in atherosclerotic plaques, suggesting a role in chronic inflammation linked to atherosclerosis. Chronic bacterial infections often form biofilms resistant to antibiotics and immune detection, giving rise to a new generation of virulent bacteria in suitable conditions. This study explores the role of the immune system in bacterial‐induced inflammation of atherosclerotic plaques. Methods: Coronary plaques from 121 sudden death victims and endarterectomy samples from 96 surgical patients were analyzed using bacterial real‐time quantitative polymerase chain reaction, immunohistochemistry, and genome‐wide expression analysis. TLR (toll‐like receptor) signaling was examined in bacterial‐activated TLR cell lines. Results: Of the bacteria detected, oral viridans group streptococcal DNA was the most common, being found in 42.1% of coronary plaques and 42.9% of endarterectomies. Immunopositivity for viridans streptococci correlated with severe atherosclerosis ( P <0.0001) in both series and death from coronary heart disease ( P =0.021) or myocardial infarction ( P =0.042). Viridans streptococci colonized the core of the atheroma as a biofilm unrecognized by macrophages of the innate immune system. In contrast, immunopositive streptococci that appeared to have originated from the biofilm infiltrated the ruptured fibrous cap of the atheroma in endarterectomy samples and coronary plaques and were detected by pattern‐recognizing receptors and coexpressed with the adaptive immune response. Among the viridans streptococcal strains, TLR2 was the most activated bacterial‐signaling pathway. Genome‐wide expression analysis of endarterectomy samples showed upregulation of bacterial recognition pathways. Conclusions: Latent chronic bacterial inflammation evades immune detection and may contribute to the pathogenesis of complicated atherosclerotic plaques and fatal myocardial infarction.
16 January 2025 in medRxiv
Background: Molecular microbial techniques have identified several DNA sequences from oral and gut bacteria in atherosclerotic plaques. The composition of the plaque microbiome has shown great heterogeneity due to varying DNA extraction and amplification methods, small size sample cohorts, and a low abundance of bacteria in plaques, leading to interference by contaminating bacterial sequences from laboratory chemicals. We used a novel next-generation sequencing (NGS) approach to analyze the entirety of bacterial DNAs found in coronary artery plaques in a unique prospective autopsy series of out-of-hospital deaths representing a cross-section of the general population. Methods: DNA was extracted from aseptically collected and frozen (−80 ° C) atherosclerotic coronary plaque samples taken from the left anterior descending (LAD) coronary arteries of 202 victims of sudden out-of-hospital death included in the Tampere Sudden Death Study. Bacterial DNA was amplified using nested 16S rRNA PCR and sequenced. Amplicon sequence variants (ASVs) were inferred using the DADA2 approach. Taxonomy assignment of the sequences was accomplished using the Silva database (version 138).The presence of bacteria in coronary artery atherosclerotic plaques was confirmed by immunohistochemistry. Results: ASVs from 230 bacteria at the genus level occurring in humans were detected in the coronary plaques. The most common ASVs detected in almost all plaques belonged to the oral biofilm-producing bacteria Veillonella and Streptococcus , which, along with Prevotella, Lactobacillus, Clostridium , and Fusobacterium were the genera with the most ASV reads following nested PCR. The immunopositivity of oral streptococci and Veillonella occurred mainly as biofilm-like structures around calcific plaque areas and associated with the severity of atherosclerosis. Conclusion: Coronary plaques harbor DNA sequences from dozens of mainly oral bacteria. However, only a few bacteria are so common that they likely have a role in the buildup of the microbiome inside a coronary artery atheroma.